SCHEMBL30156594

SCHEMBL30156594

CC(C)(O)CCCCC#N

nearest known ligand 0.44

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
TSHR P16473 2/20 0.42
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL950247 0.81
SCHEMBL11955052 0.79 TSHR (0.46) ALDH1A1TSHRTDP1MEN1KMT2A
Dimethylketone Cyanohydrin SCHEMBL28093947 0.79 TSHR (0.46) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL1269985 0.78 ALDH1A1 (0.69) ALDH1A1TDP1MEN1KMT2A
SCHEMBL14002143 0.77 TSHR (0.43) ALDH1A1TSHRTDP1MAPT
SCHEMBL12933281 0.77 TSHR (0.43) ALDH1A1TSHRTDP1MAPT
SCHEMBL13858659 0.75 TSHR (0.42) ALDH1A1TSHRTDP1MAPT
SCHEMBL15880576 0.75 ALDH1A1 (0.43) ALDH1A1
SCHEMBL2945318 0.74 ALDH1A1 (0.64) ALDH1A1TDP1
SCHEMBL3040312 0.74 ALDH1A1 (0.64) ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392432-A2 POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF Sage Therapeutics, Inc. (US) 2024-07-03 EP disclosed
WO-2023028278-A2 POSITIVE NMDA-MODULATING COMPOUNDS AND METHODS OF USE THEREOF SAGE THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed